Patents by Inventor Bhupinder Singh

Bhupinder Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250144019
    Abstract: The present invention involves novel urea compositions for oral administration, that are useful for treatment or management of hyponatremia. Also disclosed are novel methods of making the urea compositions.
    Type: Application
    Filed: January 13, 2025
    Publication date: May 8, 2025
    Inventors: Lee Souders, Bhupinder Singh
  • Publication number: 20250142019
    Abstract: In some embodiments, a computer-implemented method for coupling one or more DisplayPort source devices to a plurality of DisplayPort sink devices is provided. A matrix management engine receives capabilities of the plurality of DisplayPort sink devices. The matrix management engine determines a maximum common quality based on the capabilities of the plurality of DisplayPort sink devices. The matrix management engine, provides capabilities based on the maximum common quality for presentation to the one or more DisplayPort source devices.
    Type: Application
    Filed: October 21, 2024
    Publication date: May 1, 2025
    Applicant: Icron Technologies Corporation
    Inventors: Bhupinder Singh Rathore, Ardeshir Saghafi
  • Patent number: 12214073
    Abstract: The present invention involves novel urea compositions for oral administration, that are useful for treatment or management of hyponatremia. Also disclosed are novel methods of making the urea compositions.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: February 4, 2025
    Assignee: Nephcentric, LLC
    Inventors: Lee Souders, Bhupinder Singh
  • Publication number: 20250035765
    Abstract: A system and a method are disclosed for proximity detection using a phased antenna array including multiple antenna elements.
    Type: Application
    Filed: July 9, 2024
    Publication date: January 30, 2025
    Inventors: Paboda Viduneth Ariyarathna BERUWAWELA PATHIRANAGE, Oren ELIEZER, Gennady FEYGIN, Wan Jong KIM, Pranav DAYAL, Bhupinder Singh Sachdev
  • Publication number: 20250017876
    Abstract: The present invention relates to novel tetrahydrocurcumin (THCu) compositions, novel methods of manufacturing, and methods of using these compositions for therapeutic applications. The novel synthetic pathway(s) result in THCu compositions that generally lack hexahydrocurcumin (HHC), and include an improved impurity profile with reduced additional species that are generally present in hydrogenated curcumin compositions.
    Type: Application
    Filed: September 13, 2024
    Publication date: January 16, 2025
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Richard A. Zager
  • Patent number: 12198023
    Abstract: A method and a device for creating and training machine learning models is disclosed. In an embodiment, a method for training a machine learning model for identifying entities from data includes creating a first plurality of clusters from a first plurality of data samples in a first dataset and a second plurality of clusters from a second plurality of data samples in a second dataset. The method further includes determining a rank for each of the first plurality of clusters and a rank for each of the second plurality of clusters. The method includes retraining the machine learning model using at least one of the first plurality of clusters weighted based on the rank determined for each of the first plurality of clusters and at least one of the second plurality of clusters weighted based on the rank determined for each of the second plurality of clusters.
    Type: Grant
    Filed: September 28, 2019
    Date of Patent: January 14, 2025
    Inventors: Mridul Balaraman, Madhusudan Singh, Amit Kumar, Mrinal Gupta, Vidya Suresh, Bhupinder Singh, Kartik Nivritti Kadam
  • Patent number: 12178789
    Abstract: The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity.
    Type: Grant
    Filed: December 6, 2023
    Date of Patent: December 31, 2024
    Assignee: Renibus Therapeutics, Inc.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Richard A. Zager
  • Publication number: 20240342191
    Abstract: The inactivation of BK virus in patients diagnosed with BK virus, those receiving a kidney that is infected or suspected of being infected by BK virus, or in the transplanted kidney before, during, and/or after transplant surgery is described.
    Type: Application
    Filed: June 19, 2024
    Publication date: October 17, 2024
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Stacey Ruiz
  • Patent number: 12115138
    Abstract: The present invention relates to novel tetrahydrocurcumin (THCu) compositions, novel methods of manufacturing, and methods of using these compositions for therapeutic applications. The novel synthetic pathway(s) result in THCu compositions that generally lack hexahydrocurcumin (HHC), and include an improved impurity profile with reduced additional species that are generally present in hydrogenated curcumin compositions.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: October 15, 2024
    Assignee: RENIBUS THERAPEUTICS, INC.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Richard A. Zager
  • Patent number: 12042501
    Abstract: The inactivation of BK virus in patients diagnosed with BK virus, those receiving a kidney that is infected or suspected of being infected by BK virus, or in the transplanted kidney before, during, and/or after transplant surgery is described.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: July 23, 2024
    Assignee: Renibus Therapeutics, Inc.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Stacey Ruiz
  • Publication number: 20240226144
    Abstract: Methods of treating patients before a scheduled insult such as surgy by administering a combination of stannic protoporfin and iron sucrose are provided. The present methods provide protection to photosensitive patients and those susceptible to post-operative complications.
    Type: Application
    Filed: January 8, 2024
    Publication date: July 11, 2024
    Inventors: Donald Jeffrey Keyser, Bhupinder Singh, Stacey Ruiz
  • Patent number: 11972138
    Abstract: A data handling device includes a plurality of data storage units that are adapted for long term redundant storage of data, generate heat during operation, and are mounted in a manner allowing cooling, and data accessing circuitry adapted determine information chunks relating to data to be stored such that a subset of the information chunks suffice for reproduction of the data, select several of the plurality of data storage units, write the information chunks onto the selected data storage units, determine from which of the selected data storage units to retrieve information chunks based on temperatures of the data storage units to reproduce the data, where at least some of the subset of data storage units are mounted to be cooled by a common vertical air.
    Type: Grant
    Filed: April 17, 2020
    Date of Patent: April 30, 2024
    Inventors: Bhupinder Singh Bhullar, John Douglas Fortune
  • Publication number: 20240108589
    Abstract: The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity.
    Type: Application
    Filed: December 6, 2023
    Publication date: April 4, 2024
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Richard A. Zager
  • Patent number: 11883371
    Abstract: The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level. It also involves a quantitative measure for determining a patient's antioxidant reserve capacity.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: January 30, 2024
    Assignee: Renibus Therapeutics, Inc.
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Richard A. Zager
  • Patent number: 11860942
    Abstract: Prediction logic analyzes previous data usage activities of a customer process running on a host machine to generate a first prediction indicating that the customer process will request a first data set at a first time. The prediction logic retrieves the first data set from long-term storage and loads the first data set into memory on the host machine in advance of the first time in order to provide the customer process with access to first data set in the memory during a period between the first time and a second time. The prediction logic further generates a second prediction indicating that the customer process will not access the first data set for a threshold period of time after the second time and stores the first data set in the long-term storage at the second time.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: January 2, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Omer Baluch, Julio Delgado Mangas, Kiran-Kumar Muniswamy Reddy, Ajay Gopalakrishnan, Antoun Joubran Kanawati, Si Yin, Mukul Vijay Karnik, Vishal Parakh, Timothy Andrew Rath, Bhupinder Singh Sidana, Jared Scott Lundell
  • Patent number: 11812193
    Abstract: In some embodiments, a system for providing DisplayPort communication over an extension medium is provided. The system comprises an upstream facing port device (UFP device) and a downstream facing port device (DFP device). The UFP device is configured to conduct link training with a DisplayPort source device using first DisplayPort configuration data (DPCD). The DFP device is configured to conduct link training with the DisplayPort sink device using second DPCD different from the first DPCD. The UFP device is configured to extract video data from DisplayPort data received from the DisplayPort source device and transmit the video data to the DFP device. The DFP device is configured to receive the video data, generate DisplayPort data as specified by the second DPCD, and transmit the generated DisplayPort data to the DisplayPort sink device as specified by the second DPCD.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: November 7, 2023
    Assignee: Icron Technologies Corporation
    Inventor: Bhupinder Singh Rathore
  • Publication number: 20230317226
    Abstract: A system for blockchain based digital therapeutic devices to predict food-drug constituent interaction. This uses a set of Algorithms to collect, process, cluster, structure and analyze User input data, and a set of Algorithms to collect, process, cluster, structure and analyze Scientific Modules of Drug, Food data and associated literature. There is a also a set of Algorithms to establish credible correlation and relationship between input data sources by various advanced machines learning models to fetch the required outputs by processing, analyzing and structuring input data. A set of Algorithms is used to interact the user data with Drug-Food Scientific modules and Literature. Machine learning models to predict Drug-Food Interactions and learn user preferences and habits.
    Type: Application
    Filed: January 7, 2021
    Publication date: October 5, 2023
    Inventors: Aasif Shah, Bhupinder Singh
  • Patent number: 11734616
    Abstract: A method for reserving access to a shared space through use of a blockchain and smart contracts includes: storing a blockchain including a plurality of blocks, each block including a block header and one or more blockchain data values, wherein one of the one or more blockchain data values included in one of the plurality of blocks includes a smart contract including at least an identifier and one or more terms; receiving a reservation request, wherein the reservation request includes at least the identifier, a reservation time, a public key of a cryptographic key pair, and a digital signature generated using the private key of the cryptographic key pair; validating the digital signature using the public key; executing the smart contract using the public key and the reservation time; and transmitting one or more data values to an internet-enabled device as part of the execution of the smart contract.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: August 22, 2023
    Assignee: MASTERCARD INTERNATIONAL INCORPORATED
    Inventors: Bhupinder Singh Narang, Ashish Jain, Pulkit Gupta
  • Patent number: 11605079
    Abstract: A method of verifying the destination of a transaction between nodes in a network includes receiving transaction information corresponding to a transaction between the nodes, where the transaction information comprises a unique destination identifier and a destination name and where the unique destination identifier defines a destination account of the transaction; obtaining from a storage unit a set of names used in previous transactions to that destination account; determining at least one disparity value between the destination name and the set of names; and producing a destination verification value based on the at least one disparity value, wherein the destination verification value is used to verify whether the transaction between nodes should proceed.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: March 14, 2023
    Assignee: VOCALINK LIMITED
    Inventors: Ashish Jain, Bhupinder Singh Narang, Pulkit Gupta, Michael Alan Dewar, Jeremy Robert Stephens
  • Publication number: 20230023467
    Abstract: The inactivation of BK virus in patients diagnosed with BK virus, those receiving a kidney that is infected or suspected of being infected by BK virus, or in the transplanted kidney before, during, and/or after transplant surgery is described.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 26, 2023
    Inventors: Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Stacey Ruiz